Important information that may help in the understanding of clonal evolution during interferon therapy in JAK2 and CALR mutated MPNs Great collaboration with Plo isabelle FIM @cerubidine doi.org/10.1182/blood.…

Great discussion about #COVID vaccination and treatment with interferon at #ELN21 : seems that patients on IFN don't have more adverse events and are likely to develop highest levels of antibodies, consistent with its immunostimulant activity Andreas Hochhaus & Tiziano Barbui

In the French FIM registry with more than 1788 #MPN patients, almost 300 patients were treated with interferon: only 9% had #COVID19 and none of them developed a severe case. Preliminary results will be presented at the @sfhemato annual meeting on Thursday, stay tuned!

Et bien le FIM aussi 😁 #anagramme #PlaceAuxJeunes bienvenue !

Deux projets du FIM lauréats de l’AAP 2021 de Force_Hémato Merci & Bravo au Dr Oliver Mansier CHU de Bordeaux #JAK2 #Clonal #Thrombose et Pr JC Ianotto @CHRU_Brest #VYP #FIMBANK

📢📢 Pas besoin de 🛵✈️🛴🚜🚘🛺🚲🏍🚆pour assister à la prochaine journée scientifique du FIM qui aura lieu le 16 novembre 2021 en visioconférence! Inscription gratuite mais obligatoire Mail [email protected] Ou forms.gle/enMoQPr6CNJbbL… #MPNSM Venez nombreux!

Merci à Marie Claire pour ce focus sur la thrombocytémie essentielle, une maladie du sang peu connue faisant partie des syndromes myéloprolifératifs FIM Karin Tourmente #mpnsm #VivreAvecUneNMP marieclaire.fr/thrombocytemie…

On se prépare pour vous accueillir demain pour la Journée Scientifique 2021 du FIM ! La matinée sera dédiée aux travaux du groupe et aux actualités dans les syndromes myéloprolifératifs #mpnsm Valérie Ugo @StephaneSgir Plo isabelle Rautou Pierre-Emmanuel LEGROS Laurence

Tomorrow we'll have the pleasure to welcome Rebekka Schneider for a plenary lecture during the 2021 Annual Scientific Meeting of FIM. #mpnsm Valérie Ugo Plo isabelle @StephaneSgir

J.J. Kiladjian FIM Valérie Ugo Plo isabelle @StephaneSgir Thank you for the invitation- I am very much looking forward to the discussion- talk soon! 👍🏻

C’est le grand jour ! Accueil de l’AG et journée du FIM 2021 à partir de 9h30 ☕️😁 J.J. Kiladjian Valérie Ugo LEGROS Laurence @StephaneSgir Plo isabelle #MPNSM

Superbe session FIM sur SMP #mpnsm et dermatologie avec C. Lebbé Hôpital Saint-Louis AP-HP et JC Ianotto @CHRU_Brest, avec on l'espère des avancées à venir prochainement pour le traitement du prurit. Le suivi conjoint est en tous cas bénéfique pour les patients !

Sorry, but I'm already tired to hear in may presentations that adverse events are "tolerable" and "manageable"... from patients' point of view? Are we forced to use this language?

Idea for future meetings, a session named: "Promising preliminary, early, precursory, preparatory but amazing results of studies with less than 3 patients analyzed" (apologies for this one, don't even have the excuse of the jet lag...)

So many new therapeutic options in development for #MPNsm #ASH21 Maybe time to redefine the precise role of phlebotomy as long term treatment for Polycythemia Vera? (il Guercino, Pinacoteca Nazionale di Bologna)

Very elegant study and presentation Alba Meira Adam Mead #ASH21 #MPNsm 👏👏👏 Luckily we don't see expansion of TP53 mutant clones in patients treated with #IFN suggesting that inflammatory effect is outweighted by other biological properties... #MiceAreNotSmallHumans

Revisiting diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: guess which one is the best? Response in our study in more than 1000 patients Nabih Maslah @StephaneSgir FIM #mpnsm 👇 onlinelibrary.wiley.com/share/author/E…

Une pleine page sur les syndromes myéloprolifératifs cette semaine dans Paris Match pour mettre en lumière ces maladies du sang pas si rares #mpnsm Vivre Avec Une NMP

Still time to register! Join us for this e-conference with world-class experts happy to share their knowledge in #MPNsm with you